Crossmark

No decrease in CD4/CD8 ratio after 36 months therapy in patients switched to dual regimens containing rilpivirine

Crossref DOI link: https://doi.org/10.1016/j.eimce.2020.04.003

Published Print: 2021-02

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Tortajada, Cecilia

Castellano, Lidia

Mengual, Amando

Flores, Juan
License Information

Text and Data Mining valid from 2021-02-01
More Information

This article is maintained by: Elsevier

Article Title: No decrease in CD4/CD8 ratio after 36 months therapy in patients switched to dual regimens containing rilpivirine

Journal Title: Enfermedades infecciosas y microbiologia clinica (English ed.)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.eimce.2020.04.003

Content Type: simple-article

Copyright: © 2020 Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. All rights reserved.